Dabigatran in the prevention of venous thromboembolism after major orthopedic surgery

Dabigatran in the prevention of venous thromboembolism after major orthopedic surgery

Venous thromboembolism (VTE) is a very frequent surgical complication, especially in major orthopedic procedures. Prophylaxis with pharmacological agents, including warfarin and subcutaneous injection of either low-molecular weight heparin (LMWH) or low-dose unfractionated heparin, and/or with mecha...

Full description

Bibliographic Details
Main Author:	Orietta Zaniolo
Format:	Article
Language:	English
Published:	SEEd Medical Publishers 2009-09-01
Series:	Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:	dabigatran etexilate venous thromboembolism major orthopedic surgery cost-effectiveness
Online Access:	https://journals.seedmedicalpublishers.com/index.php/FE/article/view/172

Similar Items

Cost/effectiveness model of dabigatran in the prevention of venous thromboembolism in major orthopedic surgery: Adaptation for Italy
by: Orietta Zaniolo, et al.
Published: (2010-06-01)

Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials
by: Rosencher Nadia, et al.
Published: (2012-06-01)

Dabigatran etexilate, a novel oral direct thrombin inhibitor, for preventing thromboembolic events after knee replacement arthroplasty
by: Moghtadaee M, et al.
Published: (2012-02-01)

Thromboprophylaxis with dabigatran after total hip arthroplasty in Indian patients: A subanalysis of a double-blind, double-dummy, randomized RE-NOVATE II study
by: Rajesh Malhotra, et al.
Published: (2017-03-01)

The New Oral Anticoagulants for the Treatment of Venous Thromboembolism: A New Paradigm Shift in Antithrombotic Therapy
by: Taki Galanis, MD, et al.
Published: (2014-12-01)

Dabigatran etexilate: a direct thrombin inhibitor
by: M. Dugnani
Published: (2013-05-01)

Venous Thromboembolism in Pediatric Orthopedics
by: Amir Reza Vafaee, et al.
Published: (2016-05-01)

Dabigatran versus Enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: A randomized clinical trial
by: Ahmad Mirdamadi, et al.
Published: (2014-11-01)

Results of prophylaxis of venous thromboembolism after orthopedic operations
by: B. S. Sukovatykh, et al.
Published: (2017-10-01)

Dabigatran versus Warfarin for the Treatment of Pediatric Thromboembolism: A Pilot Randomized Trial
by: Aziz Eghbali, et al.
Published: (2020-09-01)

Contribution of novel anticoagulants fondaparinux and dabigatran to venous thromboembolism prevention
by: Antonijević Nebojša, et al.
Published: (2015-01-01)

Dabigatran in the prevention of stroke in nonvalvular atrial fibrillation: Complex clinical situations and real clinical practice
by: O N Tkacheva, et al.
Published: (2014-04-01)

Dabigatran etexilate in the prevention of cardioembolic complications in patients with non-valvular atrial fibrillation
by: IS Yavelov
Published: (2014-12-01)

Dabigatran etexilate in patients with nonvalvular atrial fibrillation: benefits of application in certain clinical situations
by: E. I. Baranova, et al.
Published: (2019-11-01)

Design and rationale of dabigatran's stroke prevention in real life in Turkey (D-SPIRIT)
by: Uğur Önsel Türk, et al.
Published: (2016-05-01)

PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
by: E. D. Kosmacheva, et al.
Published: (2015-09-01)

Prevention of venous thromboembolism with rivaroxaban and apixaban in orthopedic surgery
by: Antonijević Nebojša, et al.
Published: (2020-01-01)

New indications for dabigatran: A suggestion from a drug use evaluation study
by: Farzaneh Ashrafi, et al.
Published: (2017-01-01)

Monitoring the use of dabigatran etexilate for stroke prevention: compliance with renal function guidelines
by: Alesha J. Smith, et al.
Published: (2020-01-01)

Pharmacokinetics and Pharmacogenetics of Dabigatran
by: A. V. Savinova, et al.
Published: (2021-03-01)

Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants
by: Perka Carsten
Published: (2011-11-01)

Venous thromboembolism after lower extremity orthopedic surgery: A population‐based nationwide cohort study
by: Inger Lise Gade, et al.
Published: (2021-01-01)

The Discovery of Dabigatran Etexilate
by: Joanne evan Ryn, et al.
Published: (2013-02-01)

Bioequivalence and pharmacodynamics of a generic dabigatran etexilate capsule in healthy Chinese subjects under fasting and fed conditions
by: Xin Li, et al.
Published: (2020-04-01)

Exposure Response Supports Therapeutic Drug Monitoring for Dabigatran Etexilate in Patients with Atrial Fibrillation
by: Bryan H. Simpson, et al.
Published: (2019-07-01)

Spinal subarachnoid and subdural hematoma presenting as a Brown-Séquard-like myelopathy following minor trauma in a patient on dabigatran etexilate
by: Allen R. Wolfe, MD, MPH, et al.
Published: (2017-06-01)

The treatment of venous thromboembolism with new oral anticoagulants
by: Davide Imberti
Published: (2013-12-01)

PREVENTION OF VENOUS THROMBOEMBOLISM IN GYNECOLOGIC SURGERY
by: Maja Pakiž, et al.
Published: (2015-12-01)

Choice of Renal Function Estimator Influences Adverse Outcomes with Dabigatran Etexilate in Patients with Atrial Fibrillation
by: Bryan H. Simpson, et al.
Published: (2018-10-01)

ADVANTAGES AND DISADVANTAGES OF WARFARIN AND PRADAXA THERAPY FOR VENOUS THROMBOEMBOLISM
by: B. S. Sukovatykh, et al.
Published: (2018-01-01)

Recovery of Visual Function after Administration of Dabigatran Etexilate
by: Carl-Ludwig Schönfeld, et al.
Published: (2014-08-01)

Prevention of venous thromboembolic complications in oncological surgery (review of the literature)
by: A. M. Karsanov, et al.
Published: (2020-05-01)

EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON
by: V. I. Petrov, et al.
Published: (2016-12-01)

Direct oral anticoagulants and travel-related venous thromboembolism
by: Chamnanchanunt Supat, et al.
Published: (2018-11-01)

Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada
by: Senay A, et al.
Published: (2018-05-01)

PREVENTION OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN TRAUMAS OF LOCOMOTOR SYSTEM
by: S. S. KOPENKIN
Published: (2016-12-01)

Preventing venous thromboembolism without causing harm
by: Aaron B Holley
Published: (2021-01-01)

Budget impact analysis resulting from the use of dabigatran etexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy
by: Francesco Mennini, et al.
Published: (2012-09-01)

Extended Venous Thromboembolism Prophylaxis for High-Risk Patients Undergoing Surgery for Malignancy
by: A. Perre, et al.
Published: (2011-02-01)

Perioperative venous thromboembolic disease and the emerging role of the novel oral anticoagulants: An analysis of the implications for perioperative management
by: Martina Mookadam, et al.
Published: (2015-01-01)